Report: Dual eligibles to cost more than others in drug plan

Share this article:

Dual eligibles will cost more than other beneficiaries for prescription drug plans participating in the new drug benefit, according to data released last month.

The drug use and costs of this population "may be sharply higher than those of other Medicare beneficiaries," according to an issue brief. Mathematica Policy Research Inc. disclosed state-by-state data in its report released August 22.

Medicaid reimbursement for prescription drugs for disabled duals under 65 years old was $2,143 in 1999, nearly 50% higher than the average reimbursement for disabled duals age 65 and over. Dual eligibles who receive both Medicaid and Medicare coverage make up about 70% of nursing home residents.

The Mathematica issue brief is available at http://www.mathematica.org/.

Share this article:

More in News

Long-term care leaders need self-awareness, partnerships to avoid the 'Founder's Trap,' CEO panel advises

Long-term care leaders need self-awareness, partnerships to avoid ...

Strong leaders must be vigilant or they could stifle a company's innovation and growth, a CEO panel said Monday at the 2014 LINK LTC and Senior Living Conference in Chicago.

County nursing home weighs heroin addict plan

An Ohio county is evaluating whether 20 beds at its nursing home could be dedicated for heroin addicts during their withdrawal, according to local reports.

Coaching sessions reduce hospital readmissions, study finds

An hour-long educational coaching session and up to three follow-up phone calls reduced readmissions by 39% among Medicare patients, a new study finds.